Krebs, Fanny S. http://orcid.org/0000-0002-6291-7936
Zoete, Vincent http://orcid.org/0000-0002-2336-6537
Trottet, Maxence
Pouchon, Timothée
Bovigny, Christophe
Michielin, Olivier
Funding for this research was provided by:
Department of Fundamental Oncology of the University of Lausanne, Ludwig Lausanne Branch, and the SIB Swiss Institute of Bioinformatics
Article History
Received: 28 August 2020
Accepted: 4 February 2021
First Online: 18 March 2021
Competing interests
: V.Z. is consultant for Cellestia Biotech. O.M. is the beneficiary of research funding from Merck Sharp & Dohme, Bristol-Myers Squibb, and Roche and/or is consultant or participated to advisory boards for Novartis, Merck Sharp & Dohme, Bristol-Myers Squibb, Amgen, Roche, and GlaxoSmithKline. F.S.K., M.T., T.P., and C.B. declare no competing interest.